Clinical Trial Update: CD36 in Nutrient Delivery and Its Dysfunction [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating CD36 in nutrient delivery and its dysfunction related to insulin resistance and endothelial dysfunction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endothelial Dysfunction
• Insulin Resistance

Drugs mentioned

• CD36-related intervention

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Insulin Resistance, Endothelial Dysfunction | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-11-30